Showing results (411-420 of 928) with videos related to

Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|April 2, 2021
Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in EnglandKamlesh Khunti, Peter Knighton, Francesco Zaccardi, et al.
The Lancet. Diabetes & Endocrinology|August 18, 2020
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort studyNaomi Holman, Peter Knighton, Partha Kar, et al.
The Lancet. Diabetes & Endocrinology|May 27, 2014
Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60-64 years in the 1946 British birth cohort study: an epidemiological studyMarietta Charakida, Tauseef Khan, William Johnson, et al.
The Lancet. Diabetes & Endocrinology|January 23, 2015
Once-weekly trelagliptin versus daily alogliptin in Japanese patients with type 2 diabetes: a randomised, double-blind, phase 3, non-inferiority studyNobuya Inagaki, Hitoshi Onouchi, Hideaki Maezawa, et al.
The Lancet. Diabetes & Endocrinology|April 17, 2021
Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statementSam N Scott, Federico Y Fontana, Matt Cocks, et al.
The Lancet. Diabetes & Endocrinology|May 8, 2023
Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatmentNorbert Stefan, Matthias B Schulze
The Lancet. Diabetes & Endocrinology|June 2, 2014
Endocrine aspects of bone metastasesLorenz C Hofbauer, Tilman D Rachner, Robert E Coleman, et al.
The Lancet. Diabetes & Endocrinology|March 2, 2015
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
The Lancet. Diabetes & Endocrinology|March 31, 2015
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveysKaveh Hajifathalian, Peter Ueda, Yuan Lu, et al.
The Lancet. Diabetes & Endocrinology|March 21, 2015
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trialsJacob A Udell, Matthew A Cavender, Deepak L Bhatt, et al.
Pageof 93